CARE Ratings declares Rs 8 interim dividend, Q2 profit up 22% YoY
CARERATING · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.3 pts more than Nifty Microcap 250 and 5.4 pts more than its Capital Markets peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q2 FY26 results. Consolidated net profit rose 22% YoY to Rs 57.2 crore; revenue up 16% at Rs 136.4 crore. Interim dividend of Rs 8 per share declared on face value Rs 10 with record date November 19, 2025. Also appointed Dr. Bimal Patel as Independent Director for 3 years, granted 5,000 ESOPs at Rs 1,567, and approved selling 9.9% stake each in subsidiary CareEdge Global IFSC to SBI and NSEIFSC for Rs 5.94 crore.
Strong profit growth and dividend payout signal healthy business. Subsidiary stake sale is small and non-core. Q2 beat may lift sentiment.